GLP-1 Companion Food And Nutrition Market To Reach $11.66 Billion By 2030: Growth And Industry Trends

The Business Research Company

Glucagon-Like Peptide-1 (GLP) Companion Food And Nutrition Market Report 2026 Market Overview

The Business Research Company's GLP-1 Companion Food And Nutrition Market To Reach $11.66 Billion By 2030: Growth And Industry Trends

LONDON, GREATER LONDON, UNITED KINGDOM, September 17, 2026 /EINPresswire.com/ -- "The glucagon-like peptide-1 (GLP) companion food and nutrition sector is rapidly evolving as more people focus on metabolic health and weight management. This market is gaining traction thanks to a combination of health concerns and technological advancements, setting the stage for substantial growth in the coming years. Let’s explore the current market size, key growth drivers, regional leadership, and emerging trends shaping this industry.

Projected Market Size and Growth Trajectory of the GLP Companion Food and Nutrition Market
The glucagon-like peptide-1 (GLP) companion food and nutrition market has experienced swift expansion in recent years. It is anticipated to grow from $3.2 billion in 2025 to $4.14 billion in 2026, marking a compound annual growth rate (CAGR) of 29.2%. Looking further ahead, the market is expected to reach $11.66 billion by 2030, sustaining a CAGR of 29.6%. The historical increase stems from a rise in obesity and type 2 diabetes worldwide, greater use of pharmacological weight management treatments, growth in functional foods and dietary supplements, early clinical success with GLP-1 receptor agonist drugs, and heightened consumer focus on managing metabolic health. Future expansion will be propelled by broader adoption of GLP-1 therapies for weight and diabetes control, growing interest in personalized nutrition and precision diet plans, advances in digital health and nutrition tracking, integration of food-tech with biotechnology, and an emphasis on preventive healthcare and metabolic wellness initiatives. Key trends that will influence the market include personalized metabolic nutrition strategies supporting GLP-1 therapies, functional foods designed to enhance satiety and control appetite, meal systems with low glycemic index for glucose regulation, dietary interventions optimized for the microbiome to aid weight management, and nutrient-rich, protein-enhanced GLP-1 companion diets that help preserve muscle mass.

Download a free sample of the glucagon-like peptide-1 (glp) companion food and nutrition market report:
https://www.thebusinessresearchcompany.com/sample_request?id=73146013&type=smp&name=Glucagon-Like%20Peptide-1%20%28GLP%29%20Companion%20Food%20And%20Nutrition%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=paid&utm_campaign=Sep_PR

Understanding GLP-1 Companion Food and Nutrition
GLP-1 companion food and nutrition comprises specialized dietary products and nutrition approaches tailored to support and improve the results of GLP-1–based therapies used in managing weight and metabolic conditions. These dietary solutions generally focus on increasing feelings of fullness, stabilizing blood sugar levels, and complementing the physiological effects of GLP-1 hormones to enhance overall metabolic health.

Rising Obesity Rates as a Key Driver in the GLP Companion Food and Nutrition Market
One of the main factors propelling growth in the glucagon-like peptide-1 (GLP) companion food and nutrition market is the increasing prevalence of obesity. Obesity, a condition characterized by excessive body fat accumulation, raises the risk of diseases such as diabetes, cardiovascular issues, and hypertension. Its rise is largely driven by unhealthy eating habits—especially high intake of calorie-dense, processed, and sugar-laden foods—combined with low levels of physical activity. GLP-1 companion foods aid obesity management by providing high-protein, high-fiber nutritional formulations that promote satiety, reduce overeating, and help maintain lean muscle during calorie restriction, thereby supporting GLP-1–based weight loss therapies. For example, data from May 2025 published by the Office for Health Improvement and Disparities in the UK indicated that 64.5% of adults aged 18 and over in England were overweight or living with obesity between 2023 and 2024, a rise from 64.0% the previous year. This upward trend in obesity rates is a significant factor driving demand in the oral GLP companion food and nutrition market.

View the full glucagon-like peptide-1 (glp) companion food and nutrition market report:
https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-glp-companion-food-and-nutrition-market-report?utm_source=EINPresswire&utm_medium=paid&utm_campaign=Sep_PR

Regional Leadership and Growth Outlook for the GLP Companion Food and Nutrition Market
In 2025, North America held the position as the largest market for glucagon-like peptide-1 (GLP) companion food and nutrition. Meanwhile, the Asia-Pacific region is projected to be the fastest-growing market throughout the forecast period. The market report includes a broad geographic analysis covering Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X